SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:umu-123085"
 

Search: id:"swepub:oai:DiVA.org:umu-123085" > Increased hsCRP is ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Blyme, Adam (author)

Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis

  • Article/chapterEnglish2016

Publisher, publication year, extent ...

  • 2016-03-08
  • Informa UK Limited,2016
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-123085
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-123085URI
  • https://doi.org/10.3109/14017431.2016.1151928DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Objective To investigate relations between inflammation and aortic valve stenosis (AS) by measuring high-sensitivity C-reactive protein, at baseline (hsCRP(0)) and after 1year (hsCRP(1)) and exploring associations with aortic valve replacement (AVR). Design We examined 1423 patients from the Simvastatin and Ezetimibe in Aortic Stenosis study. Results During first year of treatment, hsCRP was reduced both in patients later receiving AVR (2.3 [0.9-4.9] to 1.8 [0.8-5.4] mg/l, p<0.001) and not receiving AVR (1.90 [0.90-4.10] to 1.3 [0.6-2.9] mg/l, p<0.001). In Cox-regression analyses, hsCRP(1) predicted later AVR (HR=1.17, p<0.001) independently of hsCRP(0) (HR=0.96, p=0.33), aortic valve area (AVA) and other risk factors. A higher rate of AVR was observed in the group with high hsCRP(0) and an increase during the first year (AVR(highCRP0CRP1inc)=47.3% versus AVR(highCRP0CRP1dec)=27.5%, p<0.01). The prognostic benefit of a 1-year reduction in hsCRP was larger in patients with high versus low hsCRP(0) eliminating the difference in incidence of AVR between high versus low hsCRP(0) (AVR(highCRP0CRP1dec)=27.5% versus AVR(lowCRP0CRP1dec)=25.8%, p=0.66) in patients with reduced hsCRP during the first year. Conclusions High hsCRP(1) or an increase in hsCRP during the first year of follow-up predicted later AVR independently of AVA, age, gender and other risk factors, although no significant improvement in C-statistics was observed.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Asferg, Camilla (author)
  • Nielsen, Olav W. (author)
  • Boman, KurtUmeå universitet,Medicin,Skelelfteå Research Unit(Swepub:umu)kubo0001 (author)
  • Gohlke-Baerwolf, Christa (author)
  • Wachtell, Kristian (author)
  • Olsen, Michael H. (author)
  • Umeå universitetMedicin (creator_code:org_t)

Related titles

  • In:Scandinavian Cardiovascular Journal: Informa UK Limited50:3, s. 138-1451401-74311651-2006

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view